A Novel Core-Shell Microcapsule for Encapsulation and 3D Culture of Embryonic Stem Cells

Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH 43210, USA
Journal of Materials Chemistry B (Impact Factor: 4.73). 02/2013; 2013(7):1002-1009. DOI: 10.1039/C2TB00058J
Source: PubMed


In this study, we report the preparation of a novel microcapsule of ~ 100 μm with a liquid (as compared to solid-like alginate hydrogel) core and an alginate-chitosan-alginate (ACA) shell for encapsulation and culture of embryonic stem (ES) cells in the miniaturized 3D space of the liquid core. Murine R1 ES cells cultured in the microcapsules were found to survive (> 90%) well and proliferate to form either a single aggregate of pluripotent cells or embryoid body (EB) of more differentiated cells in each microcapsule within 7 days, dependent on the culture medium used. This novel microcapsule technology allows massive production of the cell aggregates or EBs of uniform size and controllable pluripotency, which is important for the practical application of stem cell based therapy. Moreover, the semipermeable ACA shell was found to significantly reduce immunoglobulin G (IgG) binding to the encapsulated cells by up to 8.2 times, compared to non-encapsulated cardiac fibroblasts, mesenchymal stem cells, and ES cells. This reduction should minimize inflammatory and immune responses induced damage to the cells implanted in vivo becasue IgG binding is an important first step of the undesired host responses. Therefore, the ACA microcapsule with selective shell permeability should be of importance to advance the emerging cell-based medicine.

Download full-text


Available from: Shuting Zhao, Apr 06, 2015
  • Source
    • "Among the commonly-used carrier materials, CS is seen as one of the most promising materials for pharmaceutical applications, due to their advantages of superior biocompatibility, high charge density and non-toxicity [15] [16]. In the last few years, CS microcapsules have been already concerned as efficient delivery carriers of drugs for cancer treatment [17] [18] [19] [20] [21] [22]. The targeted materials could be encapsulated in microcapsules or immobilized on the walls of microcapsules [23] [24]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Folic acid (FA) functionalized magnetic chitosan (CS) microcapsules (FA-MCMCs) were fabricated by a simple sonochemical method. FA molecules were coupled onto the outer walls of microcapsules as targeting ligands. Oleic acid (OA) modified Fe3O4 nanoparticles (OA-Fe3O4 NPs) and hydrophobic drugs were encapsulated into microcapsules. The obtained FA-MCMCs had a well-defined spherical morphology with the average size of 0.8μm. Moreover, FA-MCMCs showed an excellent supermagnetic and molecular targeted property. Cellular uptake of C6-loaded FA-MCMCs proved that FA-MCMCs could be endocytosed into the cells with the folate receptors selectively. Besides, FA-MCMCs showed a good pH-responsive and thermosensitive property. The developed FA-MCMCs could be a promising candidate for anti-cancer drugs carriers.
    Full-text · Article · Feb 2016 · Colloids and Surfaces A Physicochemical and Engineering Aspects
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The constantly expanding repository of novel polymers and stem cells has opened up new vistas in the field of cardiac tissue engineering. Successful regeneration of the complex cardiac tissue mainly centres on the appropriate scaffold material with topographical features that mimic the native environment. The integration of stem cells on these scaffolds is expected to enhance the regeneration potential. This review elaborates on the interplay of these vital factors in achieving the functional cardiac tissue. The recent advances in polymers, nanocomposites, and stem cells from different sources are highlighted. Special emphasis is laid on the clinical trials involving stem cells and the state-of-the-art materials to obtain a balanced perspective on the translational potential of this strategy.
    Full-text · Article · Sep 2013 · Macromolecular Bioscience
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A novel core-shell microcapsule system is developed in this study to mimic the miniaturized 3D architecture of pre-hatching embryos with an aqueous liquid-like core of embryonic cells and a hydrogel-shell of zona pellucida. This is done by microfabricating a non-planar microfluidic flow-focusing device that enables one-step generation of microcapsules with an alginate hydrogel shell and an aqueous liquid core of cells from two aqueous fluids. Mouse embryonic stem (ES) cells encapsulated in the liquid core are found to survive well (>92%). Moreover, ~20 ES cells in the core can proliferate to form a single ES cell aggregate in each microcapsule within 7 days while at least a few hundred cells are usually needed by the commonly used hanging-drop method to form an embryoid body (EB) in each hanging drop. Quantitative RT-PCR analyses show significantly higher expression of pluripotency marker genes in the 3D aggregated ES cells compared to the cells under 2D culture. The aggregated ES cells can be efficiently differentiated into beating cardiomyocytes using a small molecule (cardiogenol C) without complex combination of multiple growth factors. Taken together, the novel 3D microfluidic and pre-hatching embryo-like microcapsule systems are of importance to facilitate in vitro culture of pluripotent stem cells for their ever-increasing use in modern cell-based medicine.
    Full-text · Article · Oct 2013 · Lab on a Chip
Show more